Logo image of MDWD

MEDIWOUND LTD (MDWD) Stock Overview

USA - NASDAQ:MDWD - IL0011316309 - Common Stock

18.55 USD
+0.48 (+2.66%)
Last: 10/30/2025, 8:24:23 PM

MDWD Key Statistics, Chart & Performance

Key Statistics
Market Cap237.81M
Revenue(TTM)19.86M
Net Income(TTM)-27952000
Shares12.82M
Float10.01M
52 Week High22.51
52 Week Low14.14
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.64
PEN/A
Fwd PEN/A
Earnings (Next)11-18 2025-11-18
IPO2014-03-20
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MDWD short term performance overview.The bars show the price performance of MDWD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 -4 6 8

MDWD long term performance overview.The bars show the price performance of MDWD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of MDWD is 18.55 USD. In the past month the price increased by 8.67%. In the past year, price increased by 0.98%.

MEDIWOUND LTD / MDWD Daily stock chart

MDWD Latest News, Press Relases and Analysis

MDWD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 52.29 799.29B
JNJ JOHNSON & JOHNSON 18.21 455.30B
AZN ASTRAZENECA PLC-SPONS ADR 18.55 255.30B
NVS NOVARTIS AG-SPONSORED ADR 13.7 237.35B
NVO NOVO-NORDISK A/S-SPONS ADR 12.86 222.35B
MRK MERCK & CO. INC. 11.21 215.51B
PFE PFIZER INC 7.17 138.10B
SNY SANOFI-ADR 11.52 124.14B
GSK GSK PLC-SPON ADR 7.67 94.41B
BMY BRISTOL-MYERS SQUIBB CO 6.78 92.86B
ZTS ZOETIS INC 23.17 63.86B
TAK TAKEDA PHARMACEUTIC-SP ADR 47.25 41.78B

About MDWD

Company Profile

MDWD logo image MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. ; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Company Info

MEDIWOUND LTD

42 Hayarkon Street

YAVNE 8122745 IL

CEO: Sharon Malka

Employees: 111

MDWD Company Website

MDWD Investor Relations

Phone: 972779714100

MEDIWOUND LTD / MDWD FAQ

What does MDWD do?

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. ; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.


What is the stock price of MEDIWOUND LTD today?

The current stock price of MDWD is 18.55 USD. The price increased by 2.66% in the last trading session.


Does MEDIWOUND LTD pay dividends?

MDWD does not pay a dividend.


How is the ChartMill rating for MEDIWOUND LTD?

MDWD has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists MDWD stock?

MDWD stock is listed on the Nasdaq exchange.


What sector and industry does MEDIWOUND LTD belong to?

MEDIWOUND LTD (MDWD) operates in the Health Care sector and the Pharmaceuticals industry.


Can you provide the number of employees for MEDIWOUND LTD?

MEDIWOUND LTD (MDWD) currently has 111 employees.


MDWD Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to MDWD. When comparing the yearly performance of all stocks, MDWD is a bad performer in the overall market: 62.01% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MDWD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MDWD. Both the profitability and financial health of MDWD have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MDWD Financial Highlights

Over the last trailing twelve months MDWD reported a non-GAAP Earnings per Share(EPS) of -2.64. The EPS decreased by -22.22% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -41.72%
ROE -138.93%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%-80.88%
Sales Q2Q%12.74%
EPS 1Y (TTM)-22.22%
Revenue 1Y (TTM)-1.42%

MDWD Forecast & Estimates

12 analysts have analysed MDWD and the average price target is 31.28 USD. This implies a price increase of 68.63% is expected in the next year compared to the current price of 18.55.

For the next year, analysts expect an EPS growth of 8.58% and a revenue growth 19.48% for MDWD


Analysts
Analysts83.33
Price Target31.28 (68.63%)
EPS Next Y8.58%
Revenue Next Year19.48%

MDWD Ownership

Ownership
Inst Owners36.68%
Ins Owners1.67%
Short Float %10.17%
Short Ratio8.99